TY - JOUR
T1 - Time to Resolution of Infection in COVID-19 Patients
T2 - the Experience of a Tertiary Medical Center in Israel
AU - Lubart, Emily
AU - Gal, Gilad
AU - Mizrahi, Eliyahu H.
AU - Tzabary, Ahuva
AU - Baumohl, Ehuda
AU - Pinco, Erica
AU - Idkiedek, Zuhdi
AU - Ali, Eisa Haj
AU - Berger, Maya
AU - Goltsman, Galina
N1 - Publisher Copyright:
© 2022, National Institute of Health. All rights reserved.
PY - 2022
Y1 - 2022
N2 - With the spread of coronavirus disease, reports have indicated that young patients are usually asymptomatic with a short convalescence period. The current study compared the time to resolution of infection in symptomatic and asymptomatic patients. Seventy-six patients aged 44.4 ± 23.3 years were admitted to the coronavirus disease 2019 (COVID-19) unit during the study period. Data were collected from patient records. Throat and nasal swabs for COVID-19 were collected for reverse transcriptase-polymerase chain reaction (RT-PCR). Time to resolution of infection was defined as the number of days from the date of the first COVID-19 positive outcome to the second consecutive negative PCR results. Most patients showed COVID-19 signs and symptoms (71.1%) between 1 and 6 days, and the rest were asymptomatic. No association was found between the time to resolution of infection and the presence of COVID-19 signs and symptoms (symptomatic: median [Md] 10.0, 95% confidence interval [CI] 8.4–11.6; asymptomatic: Md 15.0, 95% CI 10.5–15.5; P = 0.54). Age was not correlated with the number of COVID-19 signs and symptoms (r = 0.13, P = 0.37) or with the time to resolution of infection (r = 0.06, P = 0.58). In patients with mild to moderate symptoms, the time to resolution of infection from COVID-19 is not different from that in asymptomatic patients.
AB - With the spread of coronavirus disease, reports have indicated that young patients are usually asymptomatic with a short convalescence period. The current study compared the time to resolution of infection in symptomatic and asymptomatic patients. Seventy-six patients aged 44.4 ± 23.3 years were admitted to the coronavirus disease 2019 (COVID-19) unit during the study period. Data were collected from patient records. Throat and nasal swabs for COVID-19 were collected for reverse transcriptase-polymerase chain reaction (RT-PCR). Time to resolution of infection was defined as the number of days from the date of the first COVID-19 positive outcome to the second consecutive negative PCR results. Most patients showed COVID-19 signs and symptoms (71.1%) between 1 and 6 days, and the rest were asymptomatic. No association was found between the time to resolution of infection and the presence of COVID-19 signs and symptoms (symptomatic: median [Md] 10.0, 95% confidence interval [CI] 8.4–11.6; asymptomatic: Md 15.0, 95% CI 10.5–15.5; P = 0.54). Age was not correlated with the number of COVID-19 signs and symptoms (r = 0.13, P = 0.37) or with the time to resolution of infection (r = 0.06, P = 0.58). In patients with mild to moderate symptoms, the time to resolution of infection from COVID-19 is not different from that in asymptomatic patients.
KW - COVID-19
KW - symptomatic vs asymptomatic patients
KW - time to resolution of infection
UR - http://www.scopus.com/inward/record.url?scp=85119422029&partnerID=8YFLogxK
U2 - 10.7883/yoken.JJID.2021.215
DO - 10.7883/yoken.JJID.2021.215
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34470961
AN - SCOPUS:85119422029
SN - 1344-6304
VL - 75
SP - 144
EP - 147
JO - Japanese Journal of Infectious Diseases
JF - Japanese Journal of Infectious Diseases
IS - 2
ER -